Physio-chemical treatments for the removal of cyanotoxins from drinking water: Current challenges and future trends

Cyanobacteria are highly prevalent blue-green algae that grow in stagnant and nutrient-rich water bodies. Environmental conditions, such as eutrophication and human activities, increased the cyanobacterial blooms in freshwater resources worldwide. The excessive bloom formation has also resulted in an alarming surge of cyanobacterial toxins. Prolonged exposure to cyanotoxins is a potential threat to natural ecosystems, animal and human health by the spoilage of the quality of bathing and drinking water. Various molecular and analytical methods have been proposed to monitor their occurrence and understand their global distribution. Moreover, different physical, chemical, and biological approaches have been employed to control cyanobacterial blooms and their toxins to mitigate their occurrence. Numerous strategies have been engaged in drinking water treatment plants (DWTPs). However, the degree of treatment varies greatly and is primarily determined by the source, water properties, and operating parameters such as temperature, pH, and cyanotoxin variants and levels. A comprehensive compilation of methods, from traditional approaches to more advanced oxidation processes (AOPs), are presented for the removal of intracellular and extracellular cyanotoxins. This review discusses the effectiveness of various physicochemical operations and their limitations in a DWTP, for the removal of various cyanotoxins. These operations span from simple to advanced treatment levels with varying degrees of effectiveness and differing costs of implementation. Furthermore, mitigation measures applied in other toxin systems have been considered as alternative strategies.</p

Current perspectives on aptamers as diagnostic tools and therapeutic agents

Aptamers are synthetic single-stranded DNA or RNA sequences selected from combinatorial oligonucleotide libraries through the well-known in vitro selection and iteration process, SELEX. The last three decades have witnessed a sudden boom in aptamer research, owing to their unique characteristics, like high specificity and binding affinity, low immunogenicity and toxicity, and ease in synthesis with negligible batch-to-batch variation. Aptamers can specifically bind to the targets ranging from small molecules to complex structures, making them suitable for a myriad of diagnostic and therapeutic applications. In analytical scenarios, aptamers are used as molecular probes instead of antibodies. They have the potential in the detection of biomarkers, microorganisms, viral agents, environmental pollutants, or pathogens. For therapeutic purposes, aptamers can be further engineered with chemical stabilization and modification techniques, thus expanding their serum half-life and shelf life. A vast number of antagonistic aptamers or aptamer-based conjugates have been discovered so far through the in vitro selection procedure. However, the aptamers face several challenges for its successful clinical translation, and only particular aptamers have reached the marketplace so far. Aptamer research is still in a growing stage, and a deeper understanding of nucleic acid chemistry, target interaction, tissue distribution, and pharmacokinetics is required. In this review, we discussed aptamers in the current diagnostics and theranostics applications, while addressing the challenges associated with them. The report also sheds light on the implementation of aptamer conjugates for diagnostic purposes and, finally, the therapeutic aptamers under clinical investigation, challenges therein, and their future directions

Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents

Aptamers are synthetic single-stranded DNA or RNA sequences selected from combinatorial oligonucleotide libraries through the well-known in vitro selection and iteration process, SELEX. The last three decades have witnessed a sudden boom in aptamer research, owing to their unique characteristics, like high specificity and binding affinity, low immunogenicity and toxicity, and ease in synthesis with negligible batch-to-batch variation. Aptamers can specifically bind to the targets ranging from small molecules to complex structures, making them suitable for a myriad of diagnostic and therapeutic applications. In analytical scenarios, aptamers are used as molecular probes instead of antibodies. They have the potential in the detection of biomarkers, microorganisms, viral agents, environmental pollutants, or pathogens. For therapeutic purposes, aptamers can be further engineered with chemical stabilization and modification techniques, thus expanding their serum half-life and shelf life. A vast number of antagonistic aptamers or aptamer-based conjugates have been discovered so far through the in vitro selection procedure. However, the aptamers face several challenges for its successful clinical translation, and only particular aptamers have reached the marketplace so far. Aptamer research is still in a growing stage, and a deeper understanding of nucleic acid chemistry, target interaction, tissue distribution, and pharmacokinetics is required. In this review, we discussed aptamers in the current diagnostics and theranostics applications, while addressing the challenges associated with them. The report also sheds light on the implementation of aptamer conjugates for diagnostic purposes and, finally, the therapeutic aptamers under clinical investigation, challenges therein, and their future directions

Gold Nanoparticles and Plant Pathogens: An Overview and Prospective for Biosensing in Forestry

Plant diseases and their diagnoses are currently one of the global challenges and cause significant impact to the economy of farmers and industries depending on plant-based products. Plant pathogens such as viruses, bacteria, fungi, and pollution caused by the nanomaterial, as well as other important elements of pollution, are the main reason for the loss of plants in agriculture and in forest ecosystems. Presently, various techniques are used to detect pathogens in trees, which includes DNA-based techniques, as well as other microscopy based identification and detection. However, these methodologies require complex instruments and time. Lately, nanomaterial-based new biosensing systems for early detection of diseases, with specificity and sensitivity, are developed and applied. This review highlights the nanomaterial-based biosensing methods of disease detection. Precise and time effective identification of plant pathogens will help to reduce losses in agriculture and forestry. This review focuses on various plant diseases and the requirements for a reliable, fast, and cost-effective testing method, as well as new biosensing technologies for the detection of diseases of field plants in forests at early stages of their growth

Aptamer-based emerging tools for viral biomarker detection: a focus on SARS-CoV-2

Viral infections can cause fatal illnesses to humans as well as animals. Early detection of viruses is therefore crucial to provide effective treatment to patients. Recent-ly, the Covid-19 pandemic has undoubtedly given an alarming call to develop rapid and sensitive detection platforms. The viral diagnostic tools need to be fast, affordable, and easy to operate with high sensitivity and specificity equivalent or superior to the current-ly used diagnostic methods. The present detection methods include direct detection of viral antigens or measuring the response of antibodies to viral infections. However, the sensitivity and quantification of the virus are still a significant challenge. Detection tools em-ploying synthetic binding molecules like aptamers may provide several advantages over the conventional methods that use antibodies in the assay format. Aptamers are highly stable and tailorable molecules and are therefore ideal for detection and chemical sensing ap-plications. This review article discusses various advances made in aptamer-based viral detection platforms, including electrochemical, optical, and colorimetric methods to detect viruses, specifically SARS-Cov-2. Considering the several advantages, aptamers could be game-changing in designing high-throughput biosensors for viruses and other biomedi-cal applications in the future

Application of nanomaterials in food quality assessment

The food industry has a significant role to play in governing local economies all over the world. This sector includes some processes such as storage of raw materials, food production, and preservation. Food processing, food quality, and safety are vital to protect public health. Thus, food safety monitoring, for example, early detection of food pathogens, food-related toxins, allergens, chemicals, and enterotoxins, is of great significance. Nanoscience-based sensing platforms have become alternatives to conventional food safety monitoring techniques. Over the past few years, scientists have designed various novel nanosensors with high sensitivity and selectivity to detect a wide variety of hazardous substances. The nanomaterials, such as carbon-based nanoparticles, plasmonic/metallic nanoparticles, and inorganic fluorescent nanomaterials, have been extensively used to develop various detection platforms over the past few decades. The surface functionalization of nanoparticles using target-specific biological agents, such as aptamers and antibodies, has contributed to improving the efficiency of those nanoparticle-based diagnostic tools. In this chapter, general structural, physicochemical, and optical features of the nanoparticles were described, and their applications in food safety monitoring were reviewed. Following this, affinity agents and fundamental sensing principles employed in developing food-related hazardous substance detection tools were elaborated based on the recent publications in the literature. Finally, we expect to pave the way for enhancing the efficiency and applicability of nanosensors in the initial sensing of food-related targets that cause a significant risk for humankind worldwide

Material and design toolkit for drug delivery: state of the art, trends, and challenges

The nanomaterial and related toolkit have promising applications for improving human health and well-being. Nanobased drug delivery systems use nanoscale materials as carriers to deliver therapeutic agents in a targeted and controlled manner, and they have shown potential to address issues associated with conventional drug delivery systems. They offer benefits for treating various illnesses by encapsulating or conjugating biological agents, chemotherapeutic drugs, and immunotherapeutic agents. The potential applications of this technology are vast; however, significant challenges exist to overcome such as safety issues, toxicity, efficacy, and insufficient capacity. This article discusses the latest developments in drug delivery systems, including drug release mechanisms, material toolkits, related design molecules, and parameters. The concluding section examines the limitations and provides insights into future possibilities

Multiplex lateral flow assay and the sample preparation method for the simultaneous detection of three marine toxins

A multiplex lateral flow immunoassay (LFA) has been developed to detect the primary marine biotoxin groups: amnesic shellfish poisoning toxins, paralytic shellfish poisoning toxins, and diarrhetic shellfish poisoning toxins. The performance characteristics of the multiplex LFA were evaluated for its suitability as a screening method for the detection of toxins in shellfish. The marine toxin-specific antibodies were class-specific, and there was no cross-reactivity between the three toxin groups. The test is capable of detecting all three marine toxin groups, with working ranges of 0.2-1.5, 2.5-65.0, and 8.2-140.3 ng/mL for okadaic acid, saxitoxin, and domoic acid, respectively. This allows the multiplex LFA to detect all three toxin groups at the EU regulatory limits, with a single sample extraction method and dilution volume. No matrix effects were observed on the performance of the LFA with mussel samples spiked with toxins. The developed LFA uses a simple and pocket-sized, portable Cube Reader to provide an accurate result. We also evaluated the use of this Cube Reader with commercially available monoplex lateral flow assays for marine toxins